Insider trade

CEO sold ~$60K of HCA shares in the open market

Traded Feb 3, 2026 · Filed Feb 5, 2026

HCA HealthcareHCA

~$60K
Reported value · 120 sh @ $497.1783: 32K
Holds after · shares reported: -15.2%
stock since the trade · S&P 500 +10.8%, $499.21 → $423.39 on Oct 1

Why it stands out

The boss of HCA Healthcare sold $60K of HCA Healthcare shares. Nobody planned it ahead of time.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Feb 3, 2026
Reporting period: Not applicable
Filed with the SEC: Feb 5, 2026

CEO$25K–$100K

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$59,661

Shares × reported transaction price

Timing vs results

7 days after results of Jan 27, 2026, 80 days before results of Apr 24, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $499.21 on Feb 3, 2026, within 4% of its 52-week high, after a 7% rise over the previous 30 trading days

52-week range $306.30 (Feb 28, 2025) to $515.85 (Nov 25, 2025), 92% of the way up, from 251 adjusted closes. 30 trading days earlier: $466.56 on Dec 18, 2025. Describes the past only, not a forecast

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

After it was reported

After	Stock	S&P 500	Difference
7 days	+7.7%	-1.3%	+9.0%
30 days	+8.7%	-1.8%	+10.4%
90 days	-14.5%	+5.9%	-20.4%
180 days	-18.4%	+11.5%	-29.8%

Past results only. Not a forecast.

Source receipt

Record ID: 0001193125-26-039805
Filed / recorded: Feb 5, 2026, 11:33 PM UTC
Added to OQRO: Oct 2, 2026, 12:28 PM UTC
Parser: form4-xml-v1
Data quality: Verified: identifiers matched exactly
Issuer: HCA Healthcare, Inc.
Issuer CIK: 860730
Ticker: HCA
Reporting person: Samuel N Hazen
Relationship: Director, Officer
Officer title: CEO
Security: Common Stock
Table: Non-derivative (Table I)
Transaction date: Feb 3, 2026
Transaction code: S
Shares / units: 120
Price per share: $497.1783
Acquired / disposed: Disposed (D)
Shares owned after: 32,276
Ownership form: Direct
Amendment: No

Footnotes from the filing

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $497.10 to $497.38, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.